Tourbillon Capital Partners’s PLx Pharma PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-29,734
Closed -$3.45M – 89
2016
Q3
$3.45M Hold
29,734
– – 0.07% 68
2016
Q2
$2.36M Sell
29,734
-15,625
-34% -$1.35M 0.05% 59
2016
Q1
$3.45M Sell
45,359
-53,623
-54% -$3.41M 0.07% 60
2015
Q4
$8.87M Buy
98,982
+780
+0.8% +$74.9K 0.2% 61
2015
Q3
$11M Buy
98,202
+16,952
+21% +$1.95M 0.29% 69
2015
Q2
$8.27M Buy
+81,250
New +$8.41M 0.18% 84

Other funds holding PLXP

Tourbillon Capital Partners's PLXP Position: Q4 2016 in Review

Tourbillon Capital Partners sold out of PLx Pharma (PLXP) in Q4 2016, closing a stake of 29,734 shares — an estimated $3.45M sold.

Tourbillon Capital Partners first reported a position in PLXP in Q2 2015 and held it in 6 quarters. The position peaked at $11M in Q3 2015. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

  • Tourbillon Capital Partners reported no remaining PLx Pharma position as of Q4 2016 after selling out during the quarter.
  • Tourbillon Capital Partners sold 29,734 PLx Pharma shares in Q4 2016, an estimated $3.45M.
  • Tourbillon Capital Partners first reported a position in PLx Pharma in Q2 2015 and held it in 6 quarters.
  • Tourbillon Capital Partners's PLx Pharma position peaked at $11M in Q3 2015.
  • 19 funds tracked by Wall St. Rank held PLx Pharma as of Q4 2016.

Based on Tourbillon Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.